ELIZABETH PHILLIPS: Open Payments
NPI 1316244643 · PULASKI, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$462 in 26 payments from 10 companies in 2025. Trend: 2023 $313 · 2024 $300 · 2025 $462
Food & beverage: $462
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $136 |
| ABBVIE INC. | 4 | $76 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $57 |
| Novo Nordisk Inc | 3 | $53 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Lilly USA, LLC | 2 | $34 |
| Astellas Pharma US Inc | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Corcept Therapeutics | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: FARXIGA, VRAYLAR, CAPLYTA, TRELEGY ELLIPTA, MOUNJARO, Ozempic, Wegovy, AIRSUPRA.
Industry payments across TN — which companies pay providers there.
